To bypass these limitations in developing CNTF based drugs for brain disorders, a CNTF small-molecule peptide mimetic, Peptide 021 (P021: Ac-DGGLAG-NH2), was generated from a 4-mer CNTF peptide by the addition of adamantylated glycine at the C-terminus [40, 41]. Here, CNTF is linked to brain disorder.